Beranda › Penyakit Payudara › Texas
Uji klinis Penyakit Payudara di Texas
7 studi untuk Penyakit Payudara mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
- Cypress Innovative Breast Care Center, Cypress
Menerima pesertaStudi observasional
Usia 18 hingga 94 · Wanita · Diperbarui 17 Sep 2026 · NCT07505797Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- University of Texas MD Anderson Cancer Center, Houston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Fort Worth
- Research Site, Kingwood
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07647328IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 2 Sep 2026 · NCT06218355First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- dan 1 lainnya
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844Hormones, Outcomes, and Pain Pathways in Exercise Study
- University of Houston, Houston
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 60 · Wanita · Diperbarui 2 Jun 2026 · NCT07579182Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.